Abstract
Aqueous outflow resistance is the main pathogenetic mechanism of primary open angle glaucoma. Therefore the use of drugs that facilitate aqueous humor outflow should still represent the most specific treatment of this form of glaucoma. Thanks to the availability of new pharmacological formulations this strategy seems to obtain more consents also for the better compliance. The Authors report the results of personal clinical trials.
| Original language | English |
|---|---|
| Pages (from-to) | 41-44 |
| Number of pages | 4 |
| Journal | New Trends in Ophthalmology |
| Volume | 9 |
| Issue number | 1 |
| Publication status | Published - 1994 |
ASJC Scopus subject areas
- Ophthalmology
Fingerprint Dive into the research topics of 'Pharmacological increase of aqueous outflow in primary open angle glaucoma: Present strategies and personal experiences'. Together they form a unique fingerprint.
Cite this
Montanari, P., Troiano, P., Carabelli, I., Sammartino, A., & Miglior, M. (1994). Pharmacological increase of aqueous outflow in primary open angle glaucoma: Present strategies and personal experiences. New Trends in Ophthalmology, 9(1), 41-44.